Recent chatter on X about Willis Towers Watson (WTW) has centered around the company's strong Q2 2025 earnings report, which showcased a significant 20% jump in earnings per share and a 5% revenue increase. Many users are intrigued by the stock's 14% rise since the earnings release, though some express confusion over the high price-to-earnings ratio and question the sustainability of such growth. The discussion reflects a mix of curiosity and scrutiny as investors try to unpack the numbers.
Additionally, there’s buzz on X regarding strategic moves by Willis Towers Watson, including the launch of a new Lloyd’s syndicate aimed at providing innovative insurance capacity. Posts highlight interest in how this positions the company against competitors in the digital insurance space. This development has sparked conversations about potential long-term growth drivers for WTW.
Note: This discussion summary was generated from an AI condensation of post data.
Willis Towers Watson Congressional Stock Trading
Members of Congress have traded $WTW stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $WTW stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 04/07, 02/24 and 1 sale worth up to $15,000 on 06/26.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Willis Towers Watson Insider Trading Activity
Willis Towers Watson insiders have traded $WTW stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $WTW stock by insiders over the last 6 months:
- CARL AARON HESS (Chief Executive Officer) has made 0 purchases and 5 sales selling 10,000 shares for an estimated $3,091,315.
- JULIE JARECKE GEBAUER (Pres.-Health, Wealth & Career) sold 1,616 shares for an estimated $547,404
- ANDREW JAY KRASNER (Chief Financial Officer) sold 1,600 shares for an estimated $505,200
- ALEXIS FABER (Chief Operating Officer) sold 265 shares for an estimated $81,333
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Willis Towers Watson Hedge Fund Activity
We have seen 320 institutional investors add shares of Willis Towers Watson stock to their portfolio, and 422 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DODGE & COX added 1,278,423 shares (+inf%) to their portfolio in Q2 2025, for an estimated $391,836,649
- GAMMA INVESTING LLC removed 1,004,619 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $307,915,723
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 981,804 shares (-34.4%) from their portfolio in Q2 2025, for an estimated $300,922,926
- SOUNDWATCH CAPITAL LLC added 890,015 shares (+inf%) to their portfolio in Q2 2025, for an estimated $272,789,597
- PRICE T ROWE ASSOCIATES INC /MD/ added 834,093 shares (+449.9%) to their portfolio in Q2 2025, for an estimated $255,649,504
- ALLIANCEBERNSTEIN L.P. added 462,249 shares (+80.2%) to their portfolio in Q2 2025, for an estimated $141,679,318
- FMR LLC removed 423,399 shares (-10.9%) from their portfolio in Q2 2025, for an estimated $129,771,793
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Willis Towers Watson Analyst Ratings
Wall Street analysts have issued reports on $WTW in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 04/28/2025
- Barclays issued a "Underweight" rating on 04/11/2025
- Jefferies issued a "Buy" rating on 04/11/2025
- UBS issued a "Buy" rating on 03/18/2025
To track analyst ratings and price targets for Willis Towers Watson, check out Quiver Quantitative's $WTW forecast page.
Willis Towers Watson Price Targets
Multiple analysts have issued price targets for $WTW recently. We have seen 7 analysts offer price targets for $WTW in the last 6 months, with a median target of $366.0.
Here are some recent targets:
- Vincent Sinisi from Morgan Stanley set a target price of $345.0 on 08/18/2025
- Matthew Heimermann from Citigroup set a target price of $351.0 on 08/13/2025
- Elyse Greenspan from Wells Fargo set a target price of $369.0 on 07/10/2025
- Alex Scott from Barclays set a target price of $305.0 on 07/07/2025
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $366.0 on 04/28/2025
- Andrew Andersen from Jefferies set a target price of $371.0 on 04/11/2025
- Brian Meredith from UBS set a target price of $395.0 on 03/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
